DK4426307T3 - Ny oral farmaceutisk sammensætning og doseringsplan til behandling af progressive fibroserende interstitielle lungesygdomme - Google Patents

Ny oral farmaceutisk sammensætning og doseringsplan til behandling af progressive fibroserende interstitielle lungesygdomme

Info

Publication number
DK4426307T3
DK4426307T3 DK22835249.8T DK22835249T DK4426307T3 DK 4426307 T3 DK4426307 T3 DK 4426307T3 DK 22835249 T DK22835249 T DK 22835249T DK 4426307 T3 DK4426307 T3 DK 4426307T3
Authority
DK
Denmark
Prior art keywords
fibrositising
progressive
treatment
pharmaceutical composition
oral pharmaceutical
Prior art date
Application number
DK22835249.8T
Other languages
English (en)
Inventor
Christian Hesslinger
Verena Bauer
Sebastian Martin Bossert
Peter Nickolaus
Susan Kober
Yi Liu
Maria Sarno
Florian Voss
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=84785289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK4426307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK4426307T3 publication Critical patent/DK4426307T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
DK22835249.8T 2021-12-09 2022-12-08 Ny oral farmaceutisk sammensætning og doseringsplan til behandling af progressive fibroserende interstitielle lungesygdomme DK4426307T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163287642P 2021-12-09 2021-12-09
EP21218202 2021-12-29
EP22177750 2022-06-08
PCT/EP2022/084968 WO2023104958A1 (en) 2021-12-09 2022-12-08 New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases

Publications (1)

Publication Number Publication Date
DK4426307T3 true DK4426307T3 (da) 2025-09-15

Family

ID=84785289

Family Applications (1)

Application Number Title Priority Date Filing Date
DK22835249.8T DK4426307T3 (da) 2021-12-09 2022-12-08 Ny oral farmaceutisk sammensætning og doseringsplan til behandling af progressive fibroserende interstitielle lungesygdomme

Country Status (20)

Country Link
US (2) US20230181590A1 (da)
EP (2) EP4494700A3 (da)
JP (1) JP2024543161A (da)
KR (2) KR20260004530A (da)
AU (2) AU2022407131C1 (da)
CA (1) CA3234847A1 (da)
CL (2) CL2024001520A1 (da)
DK (1) DK4426307T3 (da)
ES (1) ES3041145T3 (da)
FI (1) FI4426307T3 (da)
HR (1) HRP20251043T1 (da)
HU (1) HUE073199T2 (da)
IL (1) IL312740A (da)
LT (1) LT4426307T (da)
MX (1) MX2024006270A (da)
PL (1) PL4426307T3 (da)
RS (1) RS67225B1 (da)
SI (1) SI4426307T1 (da)
TW (2) TW202617156A (da)
WO (1) WO2023104958A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528779A (ja) * 2022-08-09 2025-09-02 シーザン ハイスーク ファーマシューティカル カンパニー リミテッド Ｐｄｅ４ｂ阻害剤及びその用途
WO2026125461A1 (en) * 2024-12-12 2026-06-18 Boehringer Ingelheim International Gmbh Method of manufacturing a pharmaceutical composition comprising nerandomilast
WO2026125454A1 (en) * 2024-12-12 2026-06-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising nerandomilast
CN119857088A (zh) * 2025-01-22 2025-04-22 杭州畅溪制药有限公司 复方吸入粉雾剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004057618A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057645A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057594A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057595A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
HRP20090395T1 (hr) 2006-04-19 2009-08-31 Boehringer Ingelheim International Gmbh Dihidrotienpirimidini za liječenje upalnih bolesti
RU2500681C2 (ru) 2007-10-19 2013-12-10 Берингер Ингельхайм Интернациональ Гмбх Замещенные гетероциклом пиперазинодигидротиенопиримидины
SI2610258T1 (sl) 2007-10-19 2014-12-31 Boehringer Ingelheim International Gmbh Substituirani piperidino-dihidrotienopirimidini
US20130059866A1 (en) * 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
LT3700529T (lt) * 2017-10-23 2025-10-10 Naujas veikliųjų medžiagų derinys, skirtas progresuojančių fibrozinių intersticinių plaučių ligų (pf-ild) gydymui

Also Published As

Publication number Publication date
EP4494700A3 (en) 2025-04-16
SI4426307T1 (sl) 2025-12-31
EP4494700A2 (en) 2025-01-22
HUE073199T2 (hu) 2026-01-28
EP4426307A1 (en) 2024-09-11
CL2024001520A1 (es) 2024-11-22
TW202339731A (zh) 2023-10-16
MX2024006270A (es) 2024-06-11
CA3234847A1 (en) 2023-06-15
ES3041145T3 (en) 2025-11-07
RS67225B1 (sr) 2025-10-31
HRP20251043T1 (hr) 2025-10-24
AU2022407131C1 (en) 2025-10-30
EP4426307B1 (en) 2025-07-02
IL312740A (en) 2024-07-01
FI4426307T3 (fi) 2025-09-10
JP2024543161A (ja) 2024-11-19
TW202617156A (zh) 2026-05-01
PL4426307T3 (pl) 2025-11-17
KR20260004530A (ko) 2026-01-08
CL2024003616A1 (es) 2025-03-21
AU2025205402A1 (en) 2025-07-31
LT4426307T (lt) 2025-09-10
US20230181590A1 (en) 2023-06-15
WO2023104958A1 (en) 2023-06-15
AU2022407131B2 (en) 2025-06-19
US20250025466A1 (en) 2025-01-23
KR20240121251A (ko) 2024-08-08
AU2022407131A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
ZA202110597B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL279397A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
DK3937902T3 (da) Farmaceutisk doseringsform til påføring på slimhinder og fremgangsmåder til fremstilling af denne
LT4426307T (lt) Nauja geriamoji farmacinė kompozicija ir dozavimo režimas, skirti progresuojančių fibrozojuončių intersticinių plaučių ligų gydymui
EP3903796C0 (en) PREPARATION OF CARDIOMYOCYTES, ITS PREPARATION PROCESS AND ITS USE IN THE TREATMENT OF HEART FAILURE
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4011372A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING AFRICAN SWINE FEVER, AND USE
EP3685840A4 (en) PHARMACEUTICAL COMPOSITION OF COMPOUNDS FOR TREATING INFLAMMATORY SKIN DISEASES
PT2422786E (pt) Novas combinações farmacêuticas para o tratamento de doenças respiratórias
EP4000609A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES
EP4058017A4 (en) MEDICINAL FORMULATIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS
SG11202111739VA (en) Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases
IT201700109080A1 (it) Composizione per la prevenzione e/o il trattamento delle affezioni delle vie respiratorie
IL285751A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
DK3668519T3 (da) Anvendelse af ginsenosid m1 til fremstilling af et medikament til behandling af mundkræft
EP4073113A4 (en) THERAPEUTIC COMPOSITIONS COMPRISING A BETA-AMYLOID ANTIBODY OR A VACCINE FOR THE PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION
DK1567139T3 (da) Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
EP4400118A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF INTERSTITIAL CYSTITIS SYNDROME/BLADDER PAIN
EP3925623A4 (en) MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BONE DISEASES
IL327399A (en) Compounds and medicinal preparations containing them for the treatment of diseases
EP4431106A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MUSCULAR DISEASES
EP4501326A4 (en) THERAPEUTIC AGENT FOR A RESPIRATORY DISEASE
EP4217063A4 (en) PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF HUMAN HYPOCHOLINERGIC DISORDERS